Feature|Videos|September 11, 2024

Grace: Your API CDMO Partner of Choice

Bob Hughes (Research Fellow, Grace) and Brian Graves (Global Business Manager, Fine Chemicals, Grace) explain how Grace's experience as a CDMO can help customers from the lab to full-scale production.

Bob Hughes and Brian Graves sat down with Pharmaceutical Technology to highlight key elements of working alongside Grace. Learn more about:

  • How with 40 years of experience in the CDMO space, Grace is a collaborative partner with their customers throughout the entire project, from the lab to commercial-scale production
  • Grace's well-established, systematic processes for executing your next small molecule API project
  • Grace’s Fine Chemical Manufacturing Services (FCMS) and the technical expertise & operational capabilities to support your next project

Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.